FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4210971510> ?p ?o ?g. }

• W4210971510 endingPage "864" @default.
• W4210971510 startingPage "864" @default.
• W4210971510 abstract "Docetaxel, when given at the beginning of androgen deprivation therapy (ADT) for patients with metastatic hormone-sensitive prostate cancer (MHSPC), results in significantly longer overall survival than ADT alone. We aimed to investigate if the delivery of the first dose of docetaxel during the testosterone flare associated with LHRH initiation results in better clinical outcomes, as testosterone induces mitosis of prostate cancer cells, and docetaxel specifically targets cells in mitosis. We analyzed data from the CHAARTED trial which randomized MHSPC patients to ADT alone or ADT plus docetaxel. We included only patients treated with LHRH agonist and docetaxel (n = 379). The only cutoff that resulted in differences in treatment outcomes was between patients who started docetaxel 1-6 days (n = 18) compared to more than 14 days from LHRH initiation (n = 297). Actuarial median overall survival was 72 versus 57 months (p = 0.2); progression-free survival was 49 versus 17 months (p = 0.06), and freedom from castrate-resistant prostate cancer was 51 versus 18 months (p = 0.04) for patients who started docetaxel 1-6 days compared to more than 14 days from LHRH initiation, respectively. Administering docetaxel 1-6 days from the initiation of LHRH agonist for patients with MHSPC could be associated with improved clinical outcomes." @default.
• W4210971510 created "2022-02-13" @default.
• W4210971510 creator A5021553632 @default.
• W4210971510 creator A5029090221 @default.
• W4210971510 creator A5045014025 @default.
• W4210971510 creator A5056810780 @default.
• W4210971510 creator A5086012268 @default.
• W4210971510 date "2022-02-09" @default.
• W4210971510 modified "2023-10-17" @default.
• W4210971510 title "Administering Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer 1–6 Days Compared to More Than 14 Days after the Start of LHRH Agonist Is Associated with Better Clinical Outcomes Due to Androgen Flare" @default.
• W4210971510 cites W114049227 @default.
• W4210971510 cites W1464936406 @default.
• W4210971510 cites W1963569255 @default.
• W4210971510 cites W1968392281 @default.
• W4210971510 cites W1970226410 @default.
• W4210971510 cites W1993241875 @default.
• W4210971510 cites W2005958584 @default.
• W4210971510 cites W2019818051 @default.
• W4210971510 cites W2035397440 @default.
• W4210971510 cites W2087547931 @default.
• W4210971510 cites W2117299097 @default.
• W4210971510 cites W2122220268 @default.
• W4210971510 cites W2123449568 @default.
• W4210971510 cites W2135657156 @default.
• W4210971510 cites W2140675573 @default.
• W4210971510 cites W2142466432 @default.
• W4210971510 cites W2143942942 @default.
• W4210971510 cites W2150865892 @default.
• W4210971510 cites W2214621962 @default.
• W4210971510 cites W2287211520 @default.
• W4210971510 cites W2400554916 @default.
• W4210971510 cites W2524824556 @default.
• W4210971510 cites W2587183199 @default.
• W4210971510 cites W2607043398 @default.
• W4210971510 cites W2607837912 @default.
• W4210971510 cites W2773273196 @default.
• W4210971510 cites W2776596564 @default.
• W4210971510 cites W2787804990 @default.
• W4210971510 cites W2806015258 @default.
• W4210971510 cites W2898289654 @default.
• W4210971510 cites W2925371413 @default.
• W4210971510 cites W2975895768 @default.
• W4210971510 cites W3014348002 @default.
• W4210971510 cites W3032046986 @default.
• W4210971510 cites W3097348012 @default.
• W4210971510 cites W3116917655 @default.
• W4210971510 cites W3119005666 @default.
• W4210971510 cites W3128633028 @default.
• W4210971510 cites W3134646348 @default.
• W4210971510 cites W3174022783 @default.
• W4210971510 cites W3175030380 @default.
• W4210971510 cites W3197069188 @default.
• W4210971510 cites W3197992149 @default.
• W4210971510 cites W3203391087 @default.
• W4210971510 cites W4200489927 @default.
• W4210971510 doi "https://doi.org/10.3390/cancers14040864" @default.
• W4210971510 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35205611" @default.
• W4210971510 hasPublicationYear "2022" @default.
• W4210971510 type Work @default.
• W4210971510 citedByCount "2" @default.
• W4210971510 countsByYear W42109715102022 @default.
• W4210971510 countsByYear W42109715102023 @default.
• W4210971510 crossrefType "journal-article" @default.
• W4210971510 hasAuthorship W4210971510A5021553632 @default.
• W4210971510 hasAuthorship W4210971510A5029090221 @default.
• W4210971510 hasAuthorship W4210971510A5045014025 @default.
• W4210971510 hasAuthorship W4210971510A5056810780 @default.
• W4210971510 hasAuthorship W4210971510A5086012268 @default.
• W4210971510 hasBestOaLocation W42109715101 @default.
• W4210971510 hasConcept C121608353 @default.
• W4210971510 hasConcept C126322002 @default.
• W4210971510 hasConcept C126894567 @default.
• W4210971510 hasConcept C143998085 @default.
• W4210971510 hasConcept C170493617 @default.
• W4210971510 hasConcept C2777899217 @default.
• W4210971510 hasConcept C2777911890 @default.
• W4210971510 hasConcept C2778938600 @default.
• W4210971510 hasConcept C2779279991 @default.
• W4210971510 hasConcept C2780192828 @default.
• W4210971510 hasConcept C2781190966 @default.
• W4210971510 hasConcept C71315377 @default.
• W4210971510 hasConcept C71924100 @default.
• W4210971510 hasConceptScore W4210971510C121608353 @default.
• W4210971510 hasConceptScore W4210971510C126322002 @default.
• W4210971510 hasConceptScore W4210971510C126894567 @default.
• W4210971510 hasConceptScore W4210971510C143998085 @default.
• W4210971510 hasConceptScore W4210971510C170493617 @default.
• W4210971510 hasConceptScore W4210971510C2777899217 @default.
• W4210971510 hasConceptScore W4210971510C2777911890 @default.
• W4210971510 hasConceptScore W4210971510C2778938600 @default.
• W4210971510 hasConceptScore W4210971510C2779279991 @default.
• W4210971510 hasConceptScore W4210971510C2780192828 @default.
• W4210971510 hasConceptScore W4210971510C2781190966 @default.
• W4210971510 hasConceptScore W4210971510C71315377 @default.
• W4210971510 hasConceptScore W4210971510C71924100 @default.
• W4210971510 hasIssue "4" @default.
• W4210971510 hasLocation W42109715101 @default.
• W4210971510 hasLocation W42109715102 @default.

• next